Ronald J Hinklin

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

Organic letters

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry (2024)
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry 67 (16) (2024)
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, James T Brewster Ii, Adam Cook, Amy L Crooks, Cole Cruz, Natalie C Dwulet, John J Gaudino, Daniel Golec, Jacqueline A Harrison, Dylan P Hartley, Sherif H Hassanien, Erik J Hicken, Dean R Kahn, Ellen R Laird, Christine Lemieux, Nicholas Lewandowski, Joseph McCown, Matthew G McDonald, Oren McNulty, Tung-Chung Mou, Phong Nguyen, Lauren Oko, Lisa Pieti Opie, Jennifer Otten, Spencer C Peck, Viktor C Polites, Samuel D Randall, Rachel Z Rosen, Pavel Savechenkov, Helen Simpson, Anurag Singh, Drew Sparks, Kyle Wickersham, Lance Wollenberg, Christina E Wong, Jim Wong, Wen-I Wu, Mohamed S A Elsayed, Ronald J Hinklin, Tony P Tang
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry 67 (16) (2024)
Alexander E Drilon, Manish R Sharma, Melissa Lynne Johnson, Timothy Anthony Yap, Shirish M Gadgeel, Dale Nepert, Gang Feng, Micaela B Reddy, Allison S Harney, Mohamed S A Elsayed, Adam W Cook, Christina E Wong, Ronald J Hinklin, Yutong Jiang, Eric N Brown, Nickolas A Neitzel, Ellen R Laird, Wen-I Wu, Anurag Singh, Ping Wei, Keith A Ching, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy. Cancer discovery (2023)
Mohamed S A Elsayed, James F Blake, Mark L Boys, Eric Brown, Bruno D Chapsal, Mark J Chicarelli, Adam W Cook, Jay B Fell, John P Fischer, Lauren Hanson, Christine Lemieux, Matthew C Martinson, Joseph McCown, Oren T McNulty, Macedonio J Mejia, Nickolas A Neitzel, Jennifer N Otten, Martha E Rodriguez, Daniel Wilcox, Christina E Wong, Yeyun Zhou, Ronald J Hinklin
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
Mohamed S A Elsayed, James F Blake, Mark L Boys, Eric Brown, Bruno D Chapsal, Mark J Chicarelli, Adam W Cook, Jay B Fell, John P Fischer, Lauren Hanson, Christine Lemieux, Matthew C Martinson, Joseph McCown, Oren T McNulty, Macedonio J Mejia, Nickolas A Neitzel, Jennifer N Otten, Martha E Rodriguez, Daniel Wilcox, Christina E Wong, Yeyun Zhou, Ronald J Hinklin
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors. ACS medicinal chemistry letters 14 (12) (2023)
James T Brewster Ii, Samuel D Randall, John Kowalski, Cole Cruz, Richard Shoemaker, Eugene Tarlton, Ronald J Hinklin
A Decarboxylative Cross-Coupling Platform To Access 2-Heteroaryl Azetidines: Building Blocks with Application in Medicinal Chemistry. Organic letters (2022)

Ronald J Hinklin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ronald J Hinklin